CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹331 Cr | ₹268 Cr | ₹208 Cr | ₹143 Cr | ₹144 Cr |
What is the latest Total Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹331 Cr |
Mar2023 | ₹268 Cr |
Mar2022 | ₹208 Cr |
Mar2021 | ₹143 Cr |
Mar2020 | ₹144 Cr |
How is Total Current Liabilities of CAPLIN POINT LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹331 Cr | 23.61 | |
Mar2023 | ₹268 Cr | 29.04 | |
Mar2022 | ₹208 Cr | 45.38 | |
Mar2021 | ₹143 Cr | -1.02 | |
Mar2020 | ₹144 Cr | - |
Compare Total Current Liabilities of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹17,564.0 Cr | -4.6% | 18.9% | 84.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -4.6% |
18.9% |
84.5% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses